CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-02-26 | Greene John Director | Purchase | +7,000 | $44.85 | $314K | 7,000 |
| 2024-05-30 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2023-06-08 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2022-06-09 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2021-06-10 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-11 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-06-11 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 1 of 1 · 9 trades